Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
A study in PMC9704859 found it reduces symptoms
[2] [11] As of 2026, retatrutide has not received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and it remains an experimental compound available only within authorised clinical trial settings
Keywords: AOD9604, hGH Fragment 176191, Growth Hormone Peptide, Modified C-terminal Growth Hormone Peptide.
This peptide operates as a lipolytic agent, meaning it stimulates the breakdown and elimination of fat deposits
the field has since advanced to triple agonists like retatrutide
That gap is real, and it is worth resolving before you try to reconcile two sources
US$ 21.53
US$ 24.14
US$ 25.53
US$ 20.19
US$ 23.18
